FindTrial
Sign In

Urinary N-terminal titin, as a novel biomarker of skeletal muscle injury, in very early identification and screening in pediatric patients with severe myocarditis

Urinary N-terminal titin, as a novel biomarker of skeletal muscle injury, in very early identification and screening in pediatric patients with severe myocarditis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065123
Enrollment
Unknown
Registered
2022-10-28
Start date
2022-10-31
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe myocarditis

Interventions

Case series:None

Sponsors

Chengdu Women's and Children's Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
29 Days to 18 Years

Inclusion criteria

Inclusion criteria: (1) Age 29 days-18 years; (2) Pediatric patients admitted to a dual-center ICU with a pediatric critical care score and early warning score consistent with critical condition; (3) ICU stay longer than 7 days. (4) diagnosis of myocarditis.

Exclusion criteria

Exclusion criteria: (1) Non-critical patients; (2) Patients admitted to the ICU for less than 7 days; (3) Patients readmitted to the ICU; (4) diagnosis of primary neuromuscular disease; (5) Those who participated in other clinical trials in the past month; those who are considered by the investigator to be unsuitable as selected patients (poor compliance, extremely critical condition not expected to complete the trial expected to withdraw)

Design outcomes

Primary

MeasureTime frame
Urinary N-terminal titin;—

Secondary

MeasureTime frame
Creatine kinase isoenzyme,CK-MB;Cardiac Troponin I,cTnI;Echocardiography;—

Countries

China

Contacts

Public ContactXiaoli Luo

Chengdu Women's and Children's Central Hospital

55050625@qq.com15982822126

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026